RVMD
Revolution Medicines Inc
NASDAQ: RVMD · HEALTHCARE · BIOTECHNOLOGY
$153.87
+3.11% today
Updated 2026-06-12
Market cap
$32.71B
P/E ratio
—
P/S ratio
9,035.10x
EPS (TTM)
$-7.11
Dividend yield
—
52W range
$34 – $167
Volume
3.3M
Revolution Medicines Inc (RVMD) Insider transactions
Net insider activity
Net selling (40,241 shares)
Buy transactions
29
Sell transactions
71
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-26 | MANCINI, ANTHONY | See Remarks | Sale | 3,121 | — | — |
| 2026-05-26 | MANCINI, ANTHONY | See Remarks | Buy | 3,121 | $33.62 | $104928.02 |
| 2026-05-26 | MANCINI, ANTHONY | See Remarks | Sale | 2,000 | $154.06 | $308121.80 |
| 2026-05-26 | MANCINI, ANTHONY | See Remarks | Sale | 700 | $153.30 | $107311.61 |
| 2026-05-26 | MANCINI, ANTHONY | See Remarks | Sale | 421 | $154.82 | $65177.41 |
| 2026-04-27 | MANCINI, ANTHONY | See Remarks | Sale | 3,120 | — | — |
| 2026-04-27 | MANCINI, ANTHONY | See Remarks | Buy | 3,120 | $33.62 | $104894.40 |
| 2026-04-27 | MANCINI, ANTHONY | See Remarks | Sale | 1,671 | $131.66 | $220007.03 |
| 2026-04-27 | MANCINI, ANTHONY | See Remarks | Sale | 1,049 | $132.88 | $139387.76 |
| 2026-04-27 | MANCINI, ANTHONY | See Remarks | Sale | 400 | $134.34 | $53734.00 |
| 2026-04-15 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 96,756 | — | — |
| 2026-04-15 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 23,244 | — | — |
| 2026-04-15 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 120,000 | $150.09 | $18.01M |
| 2026-04-15 | GOLDSMITH, MARK A | Director, See Remarks | Buy | 96,756 | $4.73 | $457655.88 |
| 2026-04-15 | GOLDSMITH, MARK A | Director, See Remarks | Buy | 23,244 | $4.09 | $95067.96 |
| 2026-03-25 | MANCINI, ANTHONY | See Remarks | Sale | 37,450 | — | — |
| 2026-03-25 | MANCINI, ANTHONY | See Remarks | Buy | 37,450 | $33.62 | $1.26M |
| 2026-03-25 | MANCINI, ANTHONY | See Remarks | Sale | 21,086 | $95.49 | $2.01M |
| 2026-03-25 | MANCINI, ANTHONY | See Remarks | Sale | 11,036 | $96.43 | $1.06M |
| 2026-03-25 | MANCINI, ANTHONY | See Remarks | Sale | 3,128 | $94.16 | $294520.28 |
| 2026-03-25 | MANCINI, ANTHONY | See Remarks | Sale | 1,800 | $93.22 | $167801.40 |
| 2026-03-25 | MANCINI, ANTHONY | See Remarks | Sale | 400 | $97.21 | $38882.84 |
| 2026-03-19 | CISLINI, JEFF | General Counsel | Sale | 1,163 | $97.44 | $113322.72 |
| 2026-03-17 | WEI, LIN | Chief Medical Officer | Sale | 2,073 | $99.48 | $206222.87 |
| 2026-03-17 | WANG, XIAOLIN | See Remarks | Sale | 2,010 | $99.48 | $199955.60 |
| 2026-03-17 | KELSEY, STEPHEN MICHAEL | See Remarks | Sale | 4,302 | $99.48 | $427964.68 |
| 2026-03-17 | HORN, MARGARET A | Chief Operating Officer | Sale | 4,583 | $99.48 | $455918.67 |
| 2026-03-17 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 12,871 | $99.48 | $1.28M |
| 2026-03-17 | CISLINI, JEFF | General Counsel | Sale | 1,795 | $99.48 | $178567.32 |
| 2026-03-17 | ANDERS, JACK | Chief Financial Officer | Sale | 2,753 | $99.48 | $273869.54 |
| 2026-03-04 | ANDERSON, ELIZABETH M | Director | Buy | 15,000 | — | — |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 30,000 | — | — |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Buy | 30,000 | $4.09 | $122700.00 |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 21,329 | $101.60 | $2.17M |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 3,620 | $100.73 | $364659.25 |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 3,500 | $99.76 | $349150.20 |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 2,100 | $101.63 | $213431.61 |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 1,700 | $101.47 | $172506.31 |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 851 | $102.20 | $86971.69 |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 800 | $102.00 | $81598.64 |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 700 | $98.17 | $68719.56 |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 600 | $100.19 | $60115.98 |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 400 | $100.12 | $40049.00 |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 200 | $102.08 | $20416.00 |
| 2026-03-02 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 100 | $98.29 | $9829.00 |
| 2026-03-01 | WEI, LIN | Chief Medical Officer | Buy | 34,000 | — | — |
| 2026-03-01 | WEI, LIN | Chief Medical Officer | Buy | 15,100 | — | — |
| 2026-03-01 | WANG, XIAOLIN | See Remarks | Buy | 34,000 | — | — |
| 2026-03-01 | WANG, XIAOLIN | See Remarks | Buy | 15,100 | — | — |
| 2026-03-01 | KELSEY, STEPHEN MICHAEL | See Remarks | Buy | 47,600 | — | — |
| 2026-03-01 | KELSEY, STEPHEN MICHAEL | See Remarks | Buy | 21,100 | — | — |
| 2026-03-01 | HORN, MARGARET A | Chief Operating Officer | Buy | 47,600 | — | — |
| 2026-03-01 | HORN, MARGARET A | Chief Operating Officer | Buy | 21,100 | — | — |
| 2026-03-01 | GOLDSMITH, MARK A | Director, See Remarks | Buy | 128,600 | — | — |
| 2026-03-01 | GOLDSMITH, MARK A | Director, See Remarks | Buy | 57,100 | — | — |
| 2026-03-01 | CISLINI, JEFF | General Counsel | Buy | 32,500 | — | — |
| 2026-03-01 | CISLINI, JEFF | General Counsel | Buy | 14,500 | — | — |
| 2026-03-01 | ANDERS, JACK | Chief Financial Officer | Buy | 45,400 | — | — |
| 2026-03-01 | ANDERS, JACK | Chief Financial Officer | Buy | 20,200 | — | — |
| 2026-02-06 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 24,010 | — | — |
| 2026-02-06 | GOLDSMITH, MARK A | Director, See Remarks | Buy | 24,010 | $0.54 | $12965.40 |
| 2026-01-21 | CISLINI, JEFF | General Counsel | Sale | 908 | $115.60 | $104964.80 |
| 2026-01-07 | HORN, MARGARET A | Chief Operating Officer | Sale | 51,406 | — | — |
| 2026-01-07 | HORN, MARGARET A | Chief Operating Officer | Sale | 23,594 | — | — |
| 2026-01-07 | HORN, MARGARET A | Chief Operating Officer | Sale | 53,096 | $100.02 | $5.31M |
| 2026-01-07 | HORN, MARGARET A | Chief Operating Officer | Buy | 51,406 | $42.45 | $2.18M |
| 2026-01-07 | HORN, MARGARET A | Chief Operating Officer | Buy | 23,594 | $29.80 | $703101.20 |
| 2026-01-07 | HORN, MARGARET A | Chief Operating Officer | Sale | 20,204 | $101.79 | $2.06M |
| 2026-01-07 | HORN, MARGARET A | Chief Operating Officer | Sale | 1,700 | $102.90 | $174930.00 |
| 2026-01-07 | ANDERS, JACK | Chief Financial Officer | Sale | 10,000 | — | — |
| 2026-01-07 | ANDERS, JACK | Chief Financial Officer | Buy | 10,000 | $42.45 | $424500.00 |
| 2025-12-16 | KELSEY, STEPHEN MICHAEL | See Remarks | Sale | 5,447 | $76.82 | $418423.29 |
| 2025-12-16 | HORN, MARGARET A | Chief Operating Officer | Sale | 4,847 | $76.82 | $372333.45 |
| 2025-12-16 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 15,394 | $76.82 | $1.18M |
| 2025-12-16 | CISLINI, JEFF | General Counsel | Sale | 2,688 | $76.82 | $206483.83 |
| 2025-12-16 | ANDERS, JACK | Chief Financial Officer | Sale | 3,104 | $77.09 | $239288.60 |
| 2025-11-25 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 60,000 | — | — |
| 2025-11-25 | GOLDSMITH, MARK A | Director, See Remarks | Buy | 60,000 | $4.09 | $245400.00 |
| 2025-11-25 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 3,000 | $75.00 | $225000.00 |
| 2025-11-25 | ANDERS, JACK | Chief Financial Officer | Sale | 5,418 | — | — |
| 2025-11-25 | ANDERS, JACK | Chief Financial Officer | Sale | 5,418 | $74.00 | $400932.00 |
| 2025-11-18 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 20,000 | — | — |
| 2025-11-18 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 20,000 | $70.38 | $1.41M |
| 2025-11-18 | CISLINI, JEFF | General Counsel | Sale | 13,388 | — | — |
| 2025-11-18 | CISLINI, JEFF | General Counsel | Sale | 13,388 | $70.14 | $939007.54 |
| 2025-11-12 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 20,000 | — | — |
| 2025-11-12 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 50,000 | — | — |
| 2025-11-12 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 20,000 | $65.07 | $1.30M |
| 2025-11-11 | ANDERS, JACK | Chief Financial Officer | Sale | 10,000 | — | — |
| 2025-11-11 | ANDERS, JACK | Chief Financial Officer | Sale | 10,000 | $64.00 | $640000.00 |
| 2025-11-07 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 26,479 | — | — |
| 2025-11-07 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 3,521 | — | — |
| 2025-11-07 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 30,000 | $60.31 | $1.81M |
| 2025-11-07 | GOLDSMITH, MARK A | Director, See Remarks | Buy | 26,479 | $1.12 | $29656.48 |
| 2025-11-07 | GOLDSMITH, MARK A | Director, See Remarks | Buy | 3,521 | $4.09 | $14400.89 |
| 2025-10-17 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 10,000 | — | — |
| 2025-10-17 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 10,000 | $55.00 | $550000.00 |
| 2025-10-17 | CISLINI, JEFF | General Counsel | Sale | 12,000 | — | — |
| 2025-10-17 | CISLINI, JEFF | General Counsel | Buy | 12,000 | $36.57 | $438840.00 |
| 2025-10-16 | GOLDSMITH, MARK A | Director, See Remarks | Sale | 10,000 | — | — |
Frequently asked questions
Are RVMD insiders buying or selling?
Over the transactions on record, RVMD insiders have been net sellers, with about $46.59M in stock sold across 71 sales, against 14 open-market purchases.
Does insider selling at RVMD mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which RVMD insiders are selling the most?
Recent selling is concentrated in a few names. GOLDSMITH, MARK A accounts for the largest share on record, with about $29.40M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.